
Adcendo
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
About
Adcendo ApS is a biopharmaceutical company focused on the development of first-and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical need. The company is advancing a pipeline of novel ADCs designed to target specific cancer cells and deliver potent cytotoxic payloads, aiming to improve patient outcomes.
Listed competitors
Also in this space
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Shares Biotechnology, Drug Discovery
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Therapeutics
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, HealthTech
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Biotech
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- adcendo.com
- Headquarters
- Copenhagen, Denmark
- Founded
- 2017
- Employees
- 60
- Total funding
- $272M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 14 Apr 2026 | Series C | $75M | Jeito Capital |
| 25 Nov 2024 | Series B | $135M | TCG Crossover (TCGX) |
| 29 Apr 2021 | Series A | $62M | Novo Seeds, Ysios Capital |
Tech stack
Detected on adcendo.com, last scanned 23 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- Email provider
- Barracuda
- Cookie consent
- Cookiebot
Adcendo scores 26. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Adcendo trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Adcendo is 79 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Adcendo raised?
Adcendo has raised a total of $272M in funding. The most recent round on record is Series C.
How many employees does Adcendo have?
Adcendo has approximately 60 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Adcendo

